https://www.pfizer.com/news/press-release/press-release-detail/global_strategic_partners_merck_kgaa_darmstadt_germany_and_pfizer_initiate_phase_iii_study_with_avelumab_in_patients_with_stage_iiib_iv_non_small_cell_lung_cancer
Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with...
Global Strategic Partners Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Study with Avelumab* in Patients with Stage IIIb/IV Non-Small Cell Lung...
global strategic partners